Novartis Proposes Shareholder Offer in Spin-Off of Sandoz Division
Novartis Proposes Spin-Off of Sandoz Division Introduction Novartis, a Swiss drugmaker, has announced its proposal to spin off its generic medicines division, Sandoz. The company is offering its shareholders one Sandoz share for every five Novartis shares. The spin-off is expected to take place on or around October 4. Shareholder Meeting The Novartis board of…